The laboratory/technology platform "Immunology and Infectiology" (L2i) has a long experience both in the immuno-monitoring of the molecular responses of the immune system, and in the study/evolution of viremia in the context of medicines, therapeutic trials or vaccines.
These know-how allow:
- to better understand the mechanisms of immune response of hosts to vaccines, drugs and therapeutics,
- to monitor the titers and locations of infectious pathogens (viral reservoirs and pharmacological sanctuaries),
Anamnestic response of PNH vaccinated against influenza © CEA/ IDMIT